BioPrex Medical
1 known investors
BioPrex Medical develops permanent antimicrobial coatings for biomedical devices, using immobilized biocidal quaternary ammonium compounds (QACs) that kill bacteria on contact without leaching into body fluids. The non-leaching, contact-killing coatings are effective against both Gram-positive and Gram-negative bacteria and adaptable to a variety of surfaces.
BiotechMedical DevicesNew Materials